P3.cr-20 the Effect of Pembrolizumab in EGFR Mutated Lung Adenocarcinoma Patients With PD-L1 Overexpression: Two Cases Report

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1999